3Chopt Investment Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$590K Buy
1,629
+281
+21% +$96.2K 0.11% 140
2026
Q1
$474K Buy
1,348
+95
+8% +$33.9K 0.11% 143
2025
Q4
$410K Sell
1,253
-12
-0.9% -$3.81K 0.09% 159
2025
Q3
$357K Sell
1,265
-134
-10% -$38.9K 0.08% 167
2025
Q2
$391K Buy
1,399
+130
+10% +$36.8K 0.09% 160
2025
Q1
$395K Buy
+1,269
New +$375K 0.1% 148

Other funds holding AMGN

3Chopt Investment Partners's AMGN Position: Q2 2026 in Review

3Chopt Investment Partners increased its Amgen (AMGN) stake by 21% in Q2 2026, buying an estimated $96.2K and bringing the position to 1,629 shares worth $590K. The position accounts for 0.11% of the portfolio, ranked #140.

3Chopt Investment Partners first reported a position in AMGN in Q1 2025 and has held it in 6 quarters since. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • 3Chopt Investment Partners held 1,629 shares of Amgen worth $590K as of Q2 2026.
  • 3Chopt Investment Partners bought 281 Amgen shares in Q2 2026, an estimated $96.2K.
  • Amgen made up 0.11% of 3Chopt Investment Partners's portfolio in Q2 2026, its #140 holding.
  • 3Chopt Investment Partners first reported a position in Amgen in Q1 2025 and has held it in 6 quarters since.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on 3Chopt Investment Partners's 13F filing for Q2 2026, filed 29 Jul 2026.